Company:  ASSEMBLY BIOSCIENCES, INC ... (ASMB)
Form Type:  DEFA14A
Filing Date:  5/19/2020 
CIK:  0001426800 
Address:  331 OYSTER POINT BLVD.
FOURTH FLOOR
 
City, State, Zip:  SOUTH SAN FRANCISCO, California 94080 
Telephone:  (833) 409-4583 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.38  
Change: 
-0.08 (-1.79%)  
Trade Time: 
Jun 11  
Market Cap: 
$175.89M
Trade ASMB now with 

© 2021  
Description of Business
We are a clinical-stage biotechnology company advancing a novel class of oral therapeutic candidates for the treatment of chronic hepatitis B virus (HBV) infection. According to the World Health Organization (WHO), approximately 270 million people worldwide are chronically infected with HBV. Our research and development programs are pursuing multiple drug candidates designed to inhibit the HBV replication cycle and block the generation of covalently closed circular DNA (cccDNA), with the aim of discovering and developing finite and curative therapies for patients with HBV. We have discovered several novel core inhibitors, which are small molecules that directly target and allosterically modulate the HBV core (HBc) protein in a way that affects assembly and stability of HBV nucleocapsids. The ongoing COVID-19 pandemic has affected certain aspects of our business.
Register and access this filing in:     
  FORM DEFA14A
    PLEASE READ THIS NOTICE CAREFULLY IN CONJUNCTION WITH THE ...
    NOTICE OF CHANGE OF LOCATION OF 2020 ANNUAL MEETING OF ...